Back to Markets
CRCardiff Oncology Inc

Cardiff Oncology Inc

CRDFNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$1.90

+0.0600 (+3.26%)

As of 05/29/26 EDT · USD

Compare
Low: $1.48Current: $1.90High: $4.56

Key Statistics

Open

$1.87

Day High

$1.91

Day Low

$1.82

Prev. Close

$1.84

VolumeShares traded today.

766.32K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$129.90M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-2.86

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$4.56

52W LowLowest price over the past 52 weeks.

$1.48

50D MAAverage closing price over the last 50 trading days.

$1.69

200D MAAverage closing price over the last 200 trading days.

$2.08

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+6.1%

1M

+17.3%

6M

-10.0%

YTD

-28.6%

1Y

-43.3%

About

Peter Elliott is a British pharmacologist and drug developer who has initiated clinical trials across a range of disease areas, and is the co-developer of Velcade, a drug used to treat multiple myeloma.

cardiffoncology.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade CRDF

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.